Advertisement

Topics

Companies Related to "Cellerant Therapeutics Awarded Million Grant From California Institute" [Most Relevant Company Matches] RSS

17:26 EDT 20th June 2018 | BioPortfolio

Here are the most relevant search results for "Cellerant Therapeutics Awarded Million Grant From California Institute" found in our extensive corporate database of over 50,000 company records.

Showing "Cellerant Therapeutics Awarded Million Grant From California Institute" Companies 1–25 of 6,600+

Extremely Relevant

Cellerant Therapeutics Inc.

Cellerant Therapeutics is a clinical stage biotechnology company focused on the regulation of the hematopoietic (blood-forming) system. The Company is developing human stem cell and antibody therapies for oncology applications and blood-related disorders. Cellerant’s lead product, CLT-008 is currently in Phase 1 clinical trials evaluating safety in pa...


Relevant

Sanford-Burnham Medical Research Institute

Sanford-Burnham Medical Research Institute (Sanford-Burnham), formerly Burnham Institute for Medical Research, is dedicated to discovering the fundamental molecular causes of disease and devising the innovative therapies of tomorrow. Sanford-Burnham, with operations in California and Florida, is one of the fastest-growing research institutes in the country...

AE Biofuels, Inc.

AE Biofuels, Inc. is a global advanced biofuels company based in Cupertino, California developing sustainable solutions to address the world's renewable chemicals and advanced fuels needs. The company operates a 55 million gallon ethanol plant in California and received a $1.8 million California Energy Commission grant to commercialize its patent-pending n...


California Ear Institute

Founded in 1968 as the first practice to be dedicated solely to Hearing Health care in the United States, The California Ear Institute has provided more than a quarter of a million visits for patients with Surgical, Medical, Hearing Aid, Cochlear Implant, Facial Nerve Disorder and Cranial Base Disorder needs. CEI is Northern California’s premier site for treatment of ear related disorders and is...

California Life Sciences Institute

California Life Sciences Institute (CLSI) supports the foundations of innovation that have made California home to the world’s most prominent life sciences ecosystem. With a focus on the San Francisco Bay Area, CLSI’s mission is to maintain California’s leadership in life sciences innovation through support of entrepreneurship, education and career...

Juventas Therapeutics

Juventas Therapeutics, headquartered in Cleveland, OH, is a privately-held biotechnology company developing a pipeline of regenerative therapies to treat life-threatening diseases. Founded in 2007 with an exclusive license from the Cleveland Clinic, Juventas has secured nearly $10 million in venture capital and grant funding since inception. Investors include Triathlon Medical Venture Partners, ...

BioAnalyte Inc.

BioAnalyte Inc. is your biomarker discovery partner. We illuminate the path between data and discovery by connecting analytical instrumentation users to the answers that they seek. Our depth of knowledge in mass spectrometry and bioinformatics positions us at the forefront of the biomedical sector, where new ideas can save lives. We were founded in June 2001 by a former executive at ProteiGene Inc...

BioScience Writers

BioScience Writers is a group of research scientists with expertise in scientific grant development, manuscript preparation, and report editing. We have raised over $4 million in Federal and private foundation grant funds. BioScience Writers staff frequently reviews NIH grant proposals and journal submissions and thus we are very knowledgeable of the standards and expectations of reviewers. The...

Amarantus Therapeutics, Inc.

Amarantus Therapeutics, Inc. is a privately-held biotechnology company developing first-in-class disease–modifying treatments that address the underlying cause of cell death, known as apoptosis, associated with a wide range of diseases, including but not limited to, neurodegenerative and cardiovascular. The Company’s most advanced drug candidate, AMRS00...

Cellerant Therapeutics, Inc.

Embryonic Stem Cells are derived from early-stage embryos before mature organs and tissues have developed. Embryonic stem cells have the greatest potential for both self-renewal (creating large numbers of stem cells) and differentiation into many different types of mature cells (bone, muscle, blood, brain, etc.)

Jersey Health Connect

The Northern and Central New Jersey Health Information Exchange (HIE) Collaborative was officially incorporated February 1, 2010, under the name “Jersey Health Connect.” It is one of four HIEs in the state awarded economic stimulus grant funds from the $11.4 million that New Jersey Health Care Facilities Financing Authority received from the Depa...

Waterford Institute of Technology

Waterford Institute of Technology (WIT) is one of the largest Institutes of Technology in Ireland with over 10,000 students and 1,000 staff. WIT was established as a Regional Technical College in 1970, and was the first to be awarded Institute of Technology designation in 1998. The Institute conducts research and teaching across a wide variety of areas including business, engineering, science, edu...

Bavarian Nordic

Bavarian Nordic initiated the development of IMVAMUNE® in 1999 and began the first clinical study in 2001. In 2003, Bavarian Nordic was awarded a contract, valued at $29 million, from the U.S. National Institutes of Health (NIH), for the further development of IMVAMUNE®. In 2004, Bavarian Nordic was awarded its second U.S. Government contract, valued at $115 million, to continue advanced devel...

SOLOMON PARK RESEARCH INSTITUTE

Solomon Park Research Institute is a non-profit foundation specializing in neurobiological research. The institute was founded and incorporated in 1985. Initial funding for the Institute was provided by the Amyotrophic Lateral Sclerosis Society of America (ALSSOA) and subsequent research has focused largely on this disease. The Institute has also received a grant from the Amyotrophic Lateral Scl...

Yaupon Therapeutics

Yaupon Therapeutics is a privately held specialty pharmaceutical company that develops small molecule pharmaceuticals licensed from under-served academic laboratories. The company has three products in development, with one compound in pivotal studies, one compound in Phase 2 and additional compounds positioned to enter clinical development in the future. The company's business strategy is to buil...

Southern California Edison

An Edison International (NYSE:EIX) company, Southern California Edison is one of the nation’s largest electric utilities, serving a population of nearly 14 million via 4.9 million customer accounts in a 50,000-square-mile service area within Central, Coastal and Southern California.

Grant Thornton

Grant Thornton LLP is the U.S. member firm of Grant Thornton International, one of the six global accounting, tax and business advisory organizations. Through member firms in 111 countries, including 50 offices in the United States, the partners of Grant Thornton member firms provide personalized attention and the highest quality service to public and private clients around the globe.We’re think...

Ferring Research Institute Inc.

Located in San Diego, California Ferring Research Institute Inc. (FRI) is the global peptide therapeutics research center for Ferring Pharmaceuticals. FRI is committed to building a portfolio of novel, innovative peptide-based drugs and biologicals to address the high unmet medical need for patients in our therapeutic areas of interest. For more detailed i...

Development Specialists, Inc.

DSI’s outstanding service was awarded in the “Reorganization of the Year (Middle Market);” "Consumer and Retail Products (Over $50 Million) Sale of the Year;” and “Real Estate Deal of the Year (Under $500 Million)" categories.

Neon Therapeutics

Neon Therapeutics is an immuno-oncology company focused on developing novel therapeutics leveraging neoantigen biology to treat cancer. A neoantigen-based product engine will allow Neon to develop further treatment modalities including next-generation vaccines and T cell therapies targeting both personalized as well as shared neoantigens. Neon Therapeutics...

Dana-Farber Cancer Institute and the Jimmy Fund

Dana-Farber Cancer Institute, a principal teaching affiliate of Harvard Medical School, is world renowned for its leadership in adult and pediatric cancer treatment and research. Designated as a comprehensive cancer center by the National Cancer Institute (NCI), it is one of the largest recipients among independent hospitals of NCI and National Institutes ...

Institute for Diabetes Discovery

The Institute for Diabetes Discovery, LLC, (IDD) is the largest privately-held biopharmaceutical company in the United States dedicated to the research and discovery of novel drugs and therapeutics for diabetes. Founded in 1995 in Branford, Connecticut, IDD is the flagship institute under the umbrella of the Institutes for Pharmaceutical Discovery, LLC. The magnitude of the worldwide health and ec...

Traversa Therapeutics

Traversa Therapeutics, Inc. (www.traversathera.com) is a San Diego, California-based biopharmaceutical company engaged in the discovery, development and commercialization of RNAi technologies. The company strives to rapidly advance siRNA platform delivery technologies for use in its internal oncology programs and by sanofi-aventis in targeting a wide varie...

Law Offices of Scott C. Glovsky

SCOTT C. GLOVSKY is a consumer attorney in California who specializes in insurance bad faith, class action and health-related litigation. He appeared in the film SiCKO and People Magazine, and his cases have been profiled on CNN and the major networks. The Consumer Attorneys' Association of California awarded him its "Street Fighter of the Year Award" in 2008. Glovsky has been named one of Sout...

Blue Shield of California

Blue Shield of California, an independent member of the Blue Cross Blue Shield Association, is a not-for-profit health plan with 4 million members, 6,800 employees and more than $17 billion in annual revenue. Founded in 1939 and headquartered in San Francisco, Blue Shield of California and its affiliates provide health, dental, vision, Medicaid and Medi...


More From BioPortfolio on "Cellerant Therapeutics Awarded Million Grant From California Institute"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks